top of page
OWL Oncology Research Logo animation

Reflections on the 2025 SCRIP Awards in London

  • Feb 26
  • 2 min read

Celebrating Innovation and the Clinical Research Community


Back in December, the OWL Oncology Research team headed to London for the SCRIP Awards. It’s always a highlight of our year—a night to step back from the data and the day-to-day to honor the hard work happening across the global biopharma and clinical research space.


While we didn’t bring home a trophy this time, we left the evening feeling energized. Being a finalist for the second year in a row is a milestone we don’t take lightly. It’s a meaningful nod to the work our team puts in and the strength of the partnerships we’ve built across the industry.


What the SCRIP Awards Are All About

Hosted annually by Citeline, the SCRIP Awards are widely considered one of the most prestigious honors in our field. They recognize everything from breakthrough scientific discoveries and clinical advances to the strategic partnerships that make those breakthroughs possible. More than just a ceremony, it’s a global gathering of people dedicated to one goal: getting better treatments to patients.


Cheers to the 2025 Winners

The competition was incredibly stiff this year, and the room was full of organizations doing truly transformative work. We were genuinely happy to see our peers recognized for their contributions. Huge congratulations to a few of this year’s standouts:


  • Best New Drug: Syndax Pharmaceuticals’ Revuforj

  • Clinical Advance of the Year: Summit Therapeutics & Akeso

  • Best CRO (Full-Service): Parexel

  • Best CRO (Specialist): CluePoints

  • Best Oncology R&D Advance: Candel Therapeutics

  • Pharma Company of the Year: AstraZeneca

  • Lifetime Achievement: Noubar Afeyan


Every winner on that list represents a massive leap forward for patient care, and it was a privilege to celebrate alongside them.


More Than Just an Award Ceremony

For us, the night was really about the people. It gave our global team a rare chance to reconnect in person and reflect on why we do this work. Standing alongside such high-caliber organizations is an inspiring reminder of the collective effort it takes to move oncology research forward.


We had a fantastic time together and want to thank the SCRIP team for hosting such a memorable night. Congratulations again to all the winners and our fellow nominees.



Looking Ahead

Being a two-time finalist only motivates us to push harder. We remain focused on advancing oncology research through operational excellence and a genuine dedication to improving patient outcomes.


Thanks for looking back on London 2025 with us. We’re already looking forward to what we can achieve together in the coming year.

 
 
OWL Oncology Research full logoin white

At OWL Oncology Research, we build clinical operations teams that feel like an extension of yours.  Our roots are in oncology and rare diseases, but our network of seasoned professionals supports almost any therapeutic area.   We provide straightforward, cost-effective solutions, tailored to the unique needs of our clients. Our adaptable structure allows us to scale teams as your needs evolve, without unnecessary overhead. With resources located around the world, we pride ourselves on being nimble and efficient, delivering top-tier service without the pe of overhead-heavy CRO models.

OWL Oncology Research®, LLC / copyright 2010-2026 / all rights reserved.  |  Created by Alicia Nagel Creative

bottom of page